Mitchell A. Lazar, MD, PhD discusses exciting new innovations in our approach to both type I and type II diabetes including islet cell transplantation, medications for beta cell preservation and new insights into the control of obesity.
Garrett FitzGerald, MD discusses how advances in molecular biology and our understanding of the human genome will lead to a paradigm shift in how we approach the development and prescibing of medications for our patients.
Tracey Evans, MD discusses developing agents for use in the treatment of this often deadly disease.
